Susquehanna International Group’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
144,372
+95,769
| +197% | +$139K | ﹤0.01% | 5496 |
|
|
2025
Q1 | $67.1K | Buy |
48,603
+22,768
| +88% | +$31.4K | ﹤0.01% | 5962 |
|
|
2024
Q4 | $78.5K | Buy |
25,835
+15,659
| +154% | +$47.6K | ﹤0.01% | 5753 |
|
|
2024
Q3 | $50.7K | Buy |
+10,176
| New | +$50.7K | ﹤0.01% | 5285 |
|
|
2024
Q2 | – | Sell |
-297,902
| Closed | -$2.37M | – | 6572 |
|
|
2024
Q1 | $2.37M | Buy |
297,902
+193,954
| +187% | +$1.54M | ﹤0.01% | 1632 |
|
|
2023
Q4 | $606K | Buy |
103,948
+87,033
| +515% | +$507K | ﹤0.01% | 3574 |
|
|
2023
Q3 | $43.3K | Buy |
+16,915
| New | +$43.3K | ﹤0.01% | 5150 |
|